PhysIQ Inc. Receives FDA Clearance of Continuous Ambulatory Respiration Rate Algorithm

This clearance adds to their expanding portfolio of FDA-cleared cloud-based analytics, which also include QRS detection, heart rate, heart rate variability, atrial fibrillation detection, and their personalized physiology change detection analytic.

Investigators Present Study Findings of physIQ’s Novel, Artificial Intelligence-Based Continuous Patient Monitoring Solution at ACC.18

3/12/18: VA-sponsored study deployed wearable biosensors to post-acute heart failure patients and applied FDA-cleared physIQ analytics to detect vital sign anomalies; Analysis demonstrated promising predictive power of AI-based analytics in terms of sensitivity, specificity, and early warning lead time; and Study results suggest compelling potential to transform to a proactive, personalized care model for at-risk patients